RxDoctor Payments Data

Micah Bosley, MD

Family Medicine · Huntsville, TXNPI 1144666785

Payments from drug & device makers

$232in general payments, 2019–2025

Across 15 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$37
  • Pfizer$27
  • AbbVie$24
  • Novo Nordisk$23
  • Abbott$22
  • Sanofi Pasteur Inc.$20
  • plus $79 from 5 others

What the payments were for

  • Food & beverage$232100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$232 in reported general payments places this provider in the 35th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$17,448
Medicare patients
67
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide157$213,446
JardianceEmpagliflozin96$87,735
XareltoRivaroxaban50$44,321
MounjaroTirzepatide28$39,961
FarxigaDapagliflozin Propanediol24$34,529
EliquisApixaban17$24,600
TrulicityDulaglutide18$22,978
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$18,302
Janumet XrSitagliptin Phos/Metformin Hcl16$17,204
Combivent RespimatIpratropium/Albuterol Sulfate16$6,943
Breo ElliptaFluticasone/Vilanterol17$6,410
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$5,070
TrintellixVortioxetine Hydrobromide11$4,680
Levothyroxine Sodium212$3,389
Atorvastatin Calcium248$2,574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$23$213,446157 claims
Boehringer IngelheimJardiance, Combivent Respimat$16$94,678112 claims
Lilly USA, LLCMounjaro, Trulicity$17$62,93946 claims
Johnson & JohnsonXarelto$15$44,32150 claims
AstraZenecaFarxiga$19$34,52924 claims
PfizerEliquis$27$24,60017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Huntsville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →